Roles for the mycobiome in liver disease
Su-Ling Zeng, Bernd Schnabl
Abstract
Liver disease, a major cause of global mortality, has been associated with dysbiosis of the intestinal microbiota (bacteria, fungi, viruses, and other microbes). Studies have associated changes in gut bacteria with pathogenesis and severity of liver disease, but the contributions of the mycobiome (the fungal populations of the gut) to health and disease have not been well studied. We review recent findings of alterations in the composition of the mycobiota in patients with liver disease and discuss the mechanisms by which these might affect pathogenesis and disease progression. Strategies to manipulate the gut mycobiota might be developed to treat or prevent liver disease.
Topics & Concepts
MycobiotaDiseasePathogenesisLiver diseaseDysbiosisGut floraBiologyMicrobiomeMedicineMicrobiologyImmunologyPathologyBioinformaticsGastroenterologyEcologyGut microbiota and healthClostridium difficile and Clostridium perfringens researchGastrointestinal motility and disorders